Bright Minds Biosciences (DRUG) Cash & Current Investments: 2019-2020
Historic Cash & Current Investments for Bright Minds Biosciences (DRUG) over the last 2 years, with Sep 2020 value amounting to $595,127.
- Bright Minds Biosciences' Cash & Current Investments rose 36265.45% to $22.0 million in Q2 2021 from the same period last year, while for Jun 2021 it was $43.1 million, marking a year-over-year change of. This contributed to the annual value of $595,127 for FY2020, which is 882.00% up from last year.
- Bright Minds Biosciences' Cash & Current Investments amounted to $595,127 in FY2020, which was up 882.00% from $60,603 recorded in FY2019.
- In the past 5 years, Bright Minds Biosciences' Cash & Current Investments ranged from a high of $595,127 in FY2020 and a low of $60,603 during FY2019.
- Its 2-year average for Cash & Current Investments is $327,865, with a median of $327,865 in 2019.
- Data for Bright Minds Biosciences' Cash & Current Investments shows a peak YoY spiked of 882.00% (in 2020) over the last 5 years.
- Bright Minds Biosciences' Cash & Current Investments (Yearly) stood at $60,603 in 2019, then skyrocketed by 882.00% to $595,127 in 2020.